Phase II Study of IMC-A12 in Patients With Mesothelioma Who Have Been Previously Treated With Chemotherapy

NCT01160458 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

20

Enrollment

NIH

Sponsor class

Conditions

Pleural Mesothelioma
Peritoneal Mesothelioma

Interventions

DRUG: IMC-A12

Sponsor

National Cancer Institute (NCI)